Beta
Dyphylline
medication Under reviewA xanthine derivative bronchodilator used for the management of respiratory conditions like asthma and chronic bronchitis.
Research summary
Scientific evidence on dyphylline in healthy human subjects centers on pharmacokinetic and bioavailability studies, confirming rapid absorption, short half-life of about 2-2.6 hours, and high renal excretion with no observed adverse effects at tested doses up to 20 mg/kg. These studies establish bioequivalence among formulations but provide no data on clinical benefits like bronchodilation or performance enhancement in healthy people, as research prioritizes patients with respiratory conditions. Overall consensus supports its safety profile in healthy volunteers, though therapeutic applications remain unproven outside disease states.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!